biotech

Novartis Offers $4.5B for Complete Takeover of Chiron

Filed in archive Corporate and Industrial News on September 1, 2005

Novartis AG said it's offering $40 a share for the 57.8% it doesn't already own in Chiron. According to Novartis spokesman John Gilardi,

"Novartis believes this will put Chiron in a better position to resolve its key issues, especially its production issues, if it's a wholly-owned subsidiary.


Chiron received the go signal earlier this week from the US FDA to resume production of its flu vaccine, in time for production for the upcoming 2005-2006 flu season.

This is the third acquisition bid by Novartis in 2005. Earlier this year, Novartis acquired Hexal AG and Eon Labs.

Read the rest of the report from MarketWatch.

Permalink: Novartis Offers $4.5B for Complete Takeover of Chiron

Tags: flu  stocks  biotech  novartis  chiron  novartis+offers  complete+takeover  takeover+chiron 

Vote for Novartis Offers $4.5B for Complete Takeover of Chiron:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells